NUTRIFLEX® OMEGA SPECIAL B. BRAUN EMULSION FOR INFUSION

البلد: سنغافورة

اللغة: الإنجليزية

المصدر: HSA (Health Sciences Authority)

العنصر النشط:

Alanine; Arginine; Aspartic acid; Calcium chloride dihydrate; Glucose monohydrate; Glutamic acid; Glycine; Histidine hydrochloride monohydrate; Isoleucine; Leucine; Lysine hydrochloride; Magnesium acetate tetrahydrate; Methionine; Omega-3-acid triglycerides; Phenylalanine; Potassium acetate; Proline; Serine; Sodium acetate trihydrate; Sodium chloride; Sodium dihydrogen phosphate dihydrate; Sodium hydroxide; Soya-bean oil, refined; Threonine; Triglycerides, medium chain; Tryptophan; Valine; Zinc acetate dihydrate

متاح من:

B. BRAUN SINGAPORE PTE LTD

ATC رمز:

B05BA10

الشكل الصيدلاني:

INJECTION, EMULSION

تركيب:

Alanine 6.792g/1000ml; Arginine 3.780g/1000ml; Aspartic acid 2.100g/1000ml; Calcium chloride dihydrate 0.623g/1000ml; Glucose monohydrate 158.4g/1000ml; Glutamic acid 4.908g/1000ml; Glycine 2.312g/1000ml; Histidine hydrochloride monohydrate 2.368g/1000ml; Isoleucine 3.284g/1000ml; Leucine 4.384g/1000ml; Lysine hydrochloride 3.980g/1000ml; Magnesium acetate tetrahydrate 0.910g/1000ml; Methionine 2.736g/1000ml; Omega-3-acid triglycerides 4.000g/1000ml; Phenylalanine 4.916g/1000ml; Potassium acetate 3.689g/1000ml; Proline 4.760g/1000ml; Serine 4.200g/1000ml; Sodium acetate trihydrate 0.250g/1000ml; Sodium chloride 0.378g/1000ml; Sodium dihydrogen phosphate dihydrate 2.496g/1000ml; Sodium hydroxide 1.171g/1000ml; Soya-bean oil, refined 16.00g/1000ml; Threonine 2.540g/1000ml; Triglycerides, medium chain 20.00g/1000ml; Tryptophan 0.800g/1000ml; Valine 3.604g/1000ml; Zinc acetate dihydrate 7.024mg/1000ml

طريقة التعاطي:

INTRAVENOUS

نوع الوصفة الطبية :

Prescription Only

المصنعة من قبل:

B. Braun Melsungen AG

الوضع إذن:

ACTIVE

تاريخ الترخيص:

2023-03-07

خصائص المنتج

179/12629244/1122
these conditions, more frequent monitoring of serum triglycerides is
necessary to assure triglyceride elimination and stable triglyceride
levels
below 11.4 mmol/L (1000 mg/dL).
In combined hyperlipidaemias and in metabolic syndrome, triglyceride
levels react to glucose, lipids and overnutrition. Adjust dose
accordingly.
Determine and monitor other lipid and glucose sources, and drugs
interfering with their metabolism.
The presence of hypertriglyceridaemia 12 hours after lipid
administration
also indicates a disturbance of lipid metabolism.
Like
all
solutions
containing
carbohydrates,
the
administration
of
Nutriflex® Omega Special B. Braun Emulsion for Infusion can lead to
hyperglycaemia. The blood glucose level should be monitored. If there
is
hyperglycaemia, the rate of infusion should be reduced or insulin
should
be administered. If the patient is receiving other intravenous glucose
solutions concurrently, the amount of additionally administered
glucose
has to be taken into account.
An interruption of administration of the emulsion may be indicated if
the blood glucose concentration rises to above 14 mmol/L (250 mg/dL)
during administration.
Refeeding or repletion of malnourished or depleted patients may cause
hypokalaemia,
hypophosphataemia
and
hypomagnesaemia.
Close
monitoring of serum electrolytes is mandatory. Adequate
supplementation
of electrolytes according to deviations from normal values is
necessary.
Controls of the serum electrolytes, the water balance, the acid-base
balance, and of blood cell counts, coagulation status, hepatic and
renal
function are necessary.
Substitution
of
electrolytes,
vitamins
and
trace
elements
may
be
necessary as required. As Nutriflex® Omega Special B. Braun Emulsion
for Infusion contains zinc, magnesium, calcium and phosphate, care
should be taken when it is co-administered with solutions containing
these substances.
Nutriflex® Omega Special B. Braun Emulsion for Infusion is a
preparation
of complex composition. It is, therefore, strongly advisable not